BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market
ARLINGTON, VA - February 28, 2008 -- BioInformatics, LLC (http://www.gene2drug.com) - the leading market research and consulting firm serving the life science industry -- announces the publication of its latest report, "Conferences & Exhibits in the Life Sciences: What's Working Now." Exhibits at scientific conferences and trade shows are an essential element of the marketing mix, but calculating return on investment (ROI) remains elusive for most vendors. This unique report compares and contrasts the perspectives of scientific customers attending conferences with the objectives and expectations of leading life science exhibitors.
"Scientific conferences can be one of the most effective ways to get in front of a large number of customers and prospects," noted Tamara Zemlo, Ph.D., Director of Syndicated Research and Analysis at BioInformatics. "We created this report to address vendors' key questions about deciding which meetings are best to attend and exhibit at, how to budget for meetings, what booth elements attract scientists, and how to ensure the best return possible."
The report has a number of encouraging findings for scientific and lab equipment suppliers. Of the 1,000 life scientists who participated in the study, only 1% claim that they do not visit exhibit halls at scientific conferences, suggesting that, in theory, vendors have an opportunity to interact with almost all of the scientists in attendance. Additionally, 76% of the scientists surveyed report that visits to exhibit halls have influenced their purchase decisions in the past 12 months.
"Vendors providing the right kind of information that scientists need, who allow them to physically examine products, and who answer their questions in an unhurried manner will be better able to positively influence the products and instruments they buy for their labs," observed Dr. Zemlo.
In addition, scientists and vendors were asked to identify which conference organizers have the best exhibit halls. The American Association for Cancer Research and the Society for Neuroscience were ranked tops by both scientists and vendors; however, scientists and vendors reported different opinions with regard to 3rd and 4th place exhibit halls.
"While the top two choices were the same for both vendors and scientists, it's important to note that no single entity received the majority of votes for best exhibit hall," stated Dr. Zemlo. "Additionally, while write-in answers for the organizer of the best exhibit hall comprise 24% of vendors' answers, they constitute 41% of scientists' answers, reflecting the wide variety of conference options available to scientists."
This invaluable report provides suppliers and conference organizers with a roadmap for implementing a successful exhibition strategy. In "The Scientist Perspective" section, the beliefs and attitudes of 1,000 life scientists are featured, including how they select and why they attend scientific conferences as well as their expectations for exhibit halls. This section also provides information intended to help vendors attract scientists to their exhibit booths and tips to increase lead generation. In "The Vendor Perspective" section, marketing and sales executives from life science companies share their insights on how they select conferences to attend, exhibit and sponsor. This section also describes how vendors measure their conference ROI and how the emergence of new media may affect the future of trade show exhibiting.
"Conferences & Exhibits in the Life Sciences: What's Working Now" includes over 50 charts, tables and cross-tabulations of the survey data. For a complimentary Executive Summary of this report, please visit gene2drug.com/report/189/
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 36,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
For more information, please contact:
Catherine Seguin
Director of Commmunications
BioInformatics, LLC
2111 Wilson Boulevard, Suite 250
Arlington, VA 22201
703-778-3080, ext. 14
c.seguin@gene2drug.com
http://www.gene2drug.com
